Sponsor Check › Sponsor group
15 issuers linked to one sponsor · LA JOLLA, CA
Grouped because: 13 shared people, same business address (14 issuers), similar issuer names (6) · 3 issuers also list a director who sits on many unrelated issuers (not used to group) (automatic match from the filings) ·Not the same sponsor? Request a correction
Data last updated: Oct 23, 2026, 5:45 PM ET · Latest filing in this group: Oct 10, 2025 · Courts (RECAP) last checked: Oct 23, 2026, 11:54 PM ET · SEC enforcement last checked: not yet
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found so far in sources searched for 15 of 15 issuers in this group.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 23, 2026, 11:54 PM ET. Searched so far: 15 of 15 issuers in this group; 0 not yet searched (15 queued). Results are added automatically.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
Search queued. Results are added automatically; check back later or follow this page to be notified.
None found so far in sources searched for 15 of 15 issuers in this group.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 23, 2026, 11:54 PM ET. Searched so far: 15 of 15 issuers in this group; 0 not yet searched (15 queued). Results are added automatically.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
No public statement by this sponsor group has been collected yet, so there is nothing to compare. Sources compared: the sponsor's own website (known from the issuer's own filings — Form C issuer website, EDGAR company profile — an approved profile claim or Form ADV Item 1.I of its matched adviser) · SEC Form D · SEC Form ADV (IAPD) · Internet Archive · No website is on file for this sponsor group yet.
0 of 29 offerings report sales commissions; 0 report finder's fees; 0 report proceeds to related persons. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Oct 10, 2025 D File 021-560436 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 11, 2025 D File 021-557255 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 9, 2024 D File 021-521146 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 24, 2024 D File 021-519627 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 23, 2022 D File 021-465729 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 22, 2022 D/A File 021-393460 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 13, 2022 D File 021-461688 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 13, 2022 D File 021-461697 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 8, 2021 D File 021-416368 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 13, 2021 D File 021-409959 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 22, 2021 D File 021-407387 | $0 | $0 | $0 The Issuer's General Partner (or its designee) is entitled to a management fee payable by the Issuer. | None listed on this filing |
| EDGAR ↗ | Jun 28, 2021 D File 021-404438 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 30, 2021 D File 021-397786 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 12, 2021 D File 021-392167 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 24, 2021 D File 021-390393 | $0 | $0 | $0 The Issuer's General Partner (or its designee) is entitled to a management fee payable by the Issuer. | None listed on this filing |
| EDGAR ↗ | Oct 14, 2020 D File 021-377785 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 14, 2020 D File 021-370889 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 13, 2020 D File 021-370830 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 27, 2018 D File 021-311122 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 15, 2016 D File 021-274550 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Sep 13, 2016 D/A File 021-247446 | $0 | $0 | $0 (est.) Issuer's affiliate will receive a fee for management services at an annual rate as a percentage of commitments. Amount to be paid, number of years to be paid and extent paid out of adjusted gross proceeds are unknown at this time. | None listed on this filing |
| EDGAR ↗ | Jul 28, 2016 D File 021-267863 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 4, 2015 D File 021-245063 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 6, 2014 D File 021-218758 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Apr 26, 2013 D File 021-195616 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 29, 2013 D File 021-194258 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 24, 2012 D File 021-185995 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 30, 2012 D File 021-183463 | $0 | $0 | $0 (est.) Issuer's affiliate will receive a fee for management services at an annual rate as a percentage of commitments. Amount to be paid, number of years to be paid and extent paid out of adjusted gross proceeds are unknown at this time. | None listed on this filing |
| EDGAR ↗ | Jul 19, 2010 D File 021-145167 | $0 | $0 | $0 Issuer's affiliate will receive a management fee for management services at an annual rate as a percentage of commitments. Amount to be paid, number of years to be paid and extent paid out of adjusted gross proceeds are unknown at this time. | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across all 15 issuers in this group — every filing in our index, latest filing per offering (SEC file number).
0 recorded documents and 0 ownership records matched to Avalon in the sources searched.
Not found in sources searched as of Oct 23, 2026, 8:59 PM ET: Hillsborough County FL Clerk of Court Official Records daily index (publicrec.hillsclerk.com D/P/M files), 2 daily files (Oct 14, 2026 to Oct 15, 2026) — loaded Oct 23, 2026, 8:59 PM ET; Florida DOR NAL roll (Hillsborough 39) roll year 2026 — loaded Oct 23, 2026, 8:54 PM ET; Florida DOR NAL roll (Dade 23) roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV roll year 2026 — loaded Oct 23, 2026, 8:58 PM ET. Not yet searched for this group (queued): NYC ACRIS via NYC Open Data (Real Property Parties 636b-3b5g, Master bnx9-e6tj, Legals 8h5j-fqxa, Document Control Codes 7isb-wh4c) · NYC PLUTO ownership via NYC Open Data (64uk-42ks) · Cook County IL Assessor via Cook County Open Data (Parcel Sales wvhk-k5uv; Parcel Addresses 3723-97qp). Records in other counties, and recorder indexes we do not yet cover, were not searched.
Property records coverage: New York City (ACRIS recorded documents and PLUTO ownership, looked up per issuer when its page is viewed; re-checked when the page is viewed again more than 30 days after the last check); Hillsborough County FL (recorded documents from Oct 14, 2026 forward; ownership from FL DOR roll 2026); Cook County IL (assessor ownership and deed/sale records, looked up per issuer when its page is viewed); Harris County TX and Dallas County TX (assessor ownership rolls only, 2026 roll; no deed, mortgage or sale records); Miami-Dade County FL (ownership from FL DOR roll only; Clerk recorded documents not yet searched). Recorder indexes for TX, AZ, IL and WA counties, mortgages and liens outside NYC and FL, lis pendens and foreclosure notices everywhere, Miami-Dade County FL recorded documents, Maricopa County AZ, King County WA, Salt Lake County UT, and all other counties are not yet searched. Last refresh by source: Hillsborough County FL Clerk daily index Oct 23, 2026, 8:59 PM ET; Dallas Central Appraisal District ACCOUNT_INFO.CSV Oct 23, 2026, 8:58 PM ET; Harris County Appraisal District real_acct.txt Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Dade 23) Oct 23, 2026, 8:58 PM ET; Florida DOR NAL roll (Hillsborough 39) Oct 23, 2026, 8:54 PM ET. NYC and Cook County are looked up per issuer when its page is viewed; the most recent such lookup on this site finished Oct 24, 2026, 12:51 AM ET. Parties are named as the recorder's index names them (role suffixes as recorded); no address, account number or trust date is shown for an individual, and individual owners of record (home ownership) are not matched or shown. Items still in human review are not shown.
Why each issuer is here is stated in the "Linked by" column. Low-confidence links are never shown — they wait for human review.
| Source | Issuer | Linked by | Location | Industry | Filings | Sold (max) | Investors | Min. investment (latest filing) | Active |
|---|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Avalon Ventures IX, L.P. | shared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group) | LA JOLLA, CA | Pooled Investment Fund | 1 | $118,125,000 | 16 | $250,000 | 2010–2010 |
| EDGAR ↗ | Avalon Ventures X, L.P. | shared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group) | LA JOLLA, CA | Pooled Investment Fund | 1 | $201,632,653 | 27 | $250,000 | 2012–2012 |
| EDGAR ↗ | Proximal Data, Inc. | shared people | SAN DIEGO, CA | Other Technology | 3 | $2,999,996 | 2 | No minimum reported | 2012–2013 |
| EDGAR ↗ | Synthorx, Inc. | shared people, same business address | LA JOLLA, CA | Biotechnology | 3 | $26,545,402 offering $63,708,953 · similar: $2,000,000–$19,999,994 | 10 similar: 2–16 | No minimum reported similar: $10,000–$50,000 | 2014–2018 |
| EDGAR ↗ | Ankasa Regenerative Therapeutics, Inc. | shared people, same business address | LA JOLLA, CA | Biotechnology | 2 | $9,518,966 offering $12,000,012 · similar: $2,000,000–$19,999,994 | 5 similar: 2–16 | No minimum reported similar: $10,000–$50,000 | 2015–2020 |
| EDGAR ↗ | Avalon Ventures XI, L.P. | shared people, same business address, similar issuer names, director listed on many unrelated issuers (not used to group) | LA JOLLA, CA | Pooled Investment Fund | 2 | $116,525,000 offering $300,000,000 · similar: $155,000–$5,250,000 | 28 similar: 4–27 | $175,000 similar: $1,000–$100,000 | 2015–2016 |
| EDGAR ↗ | Cellular Approaches, Inc. | shared people, same business address | LA JOLLA, CA | Biotechnology | 1 | $2,560,000 offering $5,060,000 · similar: $2,000,000–$19,999,994 | 3 similar: 2–16 | No minimum reported similar: $10,000–$50,000 | 2016–2016 |
| EDGAR ↗ | Nerio Therapeutics, Inc. | shared people, same business address | LA JOLLA, CA | Biotechnology | 2 | $3,500,003 offering $10,000,005 · similar: $2,000,000–$19,999,994 | 5 similar: 2–16 | No minimum reported similar: $10,000–$50,000 | 2020–2021 |
| EDGAR ↗ | Janux Therapeutics, Inc. | shared people, same business address | La Jolla, CA | Biotechnology | 3 | $125,000,073 offering $125,000,073 · similar: $2,000,000–$19,999,994 | 22 similar: 2–16 | No minimum reported similar: $10,000–$50,000 | 2020–2021 |
| EDGAR ↗ | Avalon BioVentures SPV I, L.P. | shared people, same business address, similar issuer names | LA JOLLA, CA | Pooled Investment Fund | 1 | $45,000,000 offering $45,000,000 · similar: $155,000–$5,250,000 | 37 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2021–2021 |
| EDGAR ↗ | Enlaza Therapeutics, Inc. | shared people, same business address | LA JOLLA, CA | Pharmaceuticals | 8 | $84,000,000 offering $15,000,000 · similar: $1,694,259–$16,000,000 | 16 similar: 1–13 | No minimum reported similar: $10,000–$55,000 | 2021–2025 |
| EDGAR ↗ | Avalon BioVentures I, LP | shared people, same business address, similar issuer names | LA JOLLA, CA | Pooled Investment Fund | 1 | $0 offering $200,000,000 · similar: $155,000–$5,250,000 | 0 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2021–2021 |
| EDGAR ↗ | Avalon BioVentures SPV II, L.P. | shared people, same business address, similar issuer names | LA JOLLA, CA | Pooled Investment Fund | 1 | $21,040,000 offering $21,040,000 · similar: $155,000–$5,250,000 | 8 similar: 4–27 | No minimum reported similar: $1,000–$100,000 | 2022–2022 |
| EDGAR ↗ | Valora Therapeutics, Inc. | shared people, same business address | LA JOLLA, CA | Biotechnology | 1 | $13,039,726 offering $29,185,231 · similar: $2,000,000–$19,999,994 | 12 similar: 2–16 | No minimum reported similar: $10,000–$50,000 | 2024–2024 |
| EDGAR ↗ | AeroRx Therapeutics, Inc. | shared people, same business address | LA JOLLA, CA | Other Health Care | 1 | $10,376,003 offering $20,751,992 · similar: $829,831–$9,999,998 | 17 similar: 2–15 | No minimum reported similar: $10,000–$54,310 | 2025–2025 |
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); Pooled Investment Fund / 506(b) (83,801 filings); Pharmaceuticals / 506(b) (800 filings); Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
| Source | Filed | Issuer | Form | Industry | Offered | Sold |
|---|---|---|---|---|---|---|
| EDGAR ↗ | Oct 10, 2025 | AeroRx Therapeutics, Inc. | D | Other Health Care | $20,751,992 | $10,376,003 |
| EDGAR ↗ | Sep 11, 2025 | Enlaza Therapeutics, Inc. | D | Pharmaceuticals | $15,000,000 | $15,000,000 |
| EDGAR ↗ | Aug 9, 2024 | Enlaza Therapeutics, Inc. | D | Pharmaceuticals | $110,000,000 | $84,000,000 |
| EDGAR ↗ | Jul 24, 2024 | Valora Therapeutics, Inc. | D | Biotechnology | $29,185,231 | $13,039,726 |
| EDGAR ↗ | Nov 23, 2022 | Avalon BioVentures SPV II, L.P. | D | Pooled Investment Fund | $21,040,000 | $21,040,000 |
| EDGAR ↗ | Nov 22, 2022 | Enlaza Therapeutics, Inc. | D/A | Pharmaceuticals | $61,330,607 | $35,299,237 |
| EDGAR ↗ | Oct 13, 2022 | Enlaza Therapeutics, Inc. | D | Pharmaceuticals | $311,977 | $0 |
| EDGAR ↗ | Oct 13, 2022 | Enlaza Therapeutics, Inc. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | Oct 8, 2021 | Nerio Therapeutics, Inc. | D | Biotechnology | $10,000,005 | $3,500,003 |
| EDGAR ↗ | Aug 13, 2021 | Enlaza Therapeutics, Inc. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | Jul 22, 2021 | Avalon BioVentures I, LP | D | Pooled Investment Fund | $200,000,000 | $0 |
| EDGAR ↗ | Jun 28, 2021 | Enlaza Therapeutics, Inc. | D | Pharmaceuticals | Indefinite | $0 |
| EDGAR ↗ | Apr 30, 2021 | Janux Therapeutics, Inc. | D | Biotechnology | $125,000,073 | $125,000,073 |
| EDGAR ↗ | Mar 25, 2021 | Enlaza Therapeutics, Inc. | D | Pharmaceuticals | $21,273,287 | $4,018,630 |
| EDGAR ↗ | Mar 12, 2021 | Janux Therapeutics, Inc. | D | Biotechnology | $56,000,030 | $56,000,030 |
| EDGAR ↗ | Feb 24, 2021 | Avalon BioVentures SPV I, L.P. | D | Pooled Investment Fund | $45,000,000 | $45,000,000 |
| EDGAR ↗ | Oct 14, 2020 | Ankasa Regenerative Therapeutics, Inc. | D | Biotechnology | $12,000,012 | $6,000,006 |
| EDGAR ↗ | Jul 14, 2020 | Janux Therapeutics, Inc. | D | Biotechnology | $15,939,220 | $11,439,224 |
| EDGAR ↗ | Jul 13, 2020 | Nerio Therapeutics, Inc. | D | Biotechnology | $5,752,853 | $3,002,850 |
| EDGAR ↗ | Apr 27, 2018 | Synthorx, Inc. | D | Biotechnology | $63,708,953 | $26,545,402 |
| EDGAR ↗ | Nov 15, 2016 | Cellular Approaches, Inc. | D | Biotechnology | $5,060,000 | $2,560,000 |
| EDGAR ↗ | Sep 13, 2016 | Avalon Ventures XI, L.P. | D/A | Pooled Investment Fund | $300,000,000 | $116,525,000 |
| EDGAR ↗ | Jul 28, 2016 | Synthorx, Inc. | D | Biotechnology | $10,000,001 | $5,000,000 |
| EDGAR ↗ | Sep 11, 2015 | Avalon Ventures XI, L.P. | D | Pooled Investment Fund | $300,000,000 | $103,525,000 |
| EDGAR ↗ | Aug 4, 2015 | Ankasa Regenerative Therapeutics, Inc. | D | Pharmaceuticals | $19,998,970 | $9,518,966 |
| EDGAR ↗ | Jun 6, 2014 | Synthorx, Inc. | D | Biotechnology | $6,250,000 | $3,125,000 |
| EDGAR ↗ | Apr 26, 2013 | Proximal Data, Inc. | D | Other Technology | $1,000,000 | $1,000,000 |
| EDGAR ↗ | Mar 29, 2013 | Proximal Data, Inc. | D | Other Technology | $2,000,000 | $2,000,000 |
| EDGAR ↗ | Oct 24, 2012 | Proximal Data, Inc. | D | Other Technology | $2,999,996 | $2,999,996 |
| EDGAR ↗ | Aug 30, 2012 | Avalon Ventures X, L.P. | D | Pooled Investment Fund | $250,000,000 | $201,632,653 |
| EDGAR ↗ | Jul 19, 2010 | Avalon Ventures IX, L.P. | D | Pooled Investment Fund | $200,000,000 | $118,125,000 |
Activity: 0 new offerings in the last 12 months across all issuers in this group (new offering = a Form D that is not an amendment, D/A) · most recent filing Oct 10, 2025. Industry history, as reported on each offering's latest filing: Previous offerings: Pooled Investment Fund (2010–2012), Other Technology (2012–2013), Biotechnology (2014), Pharmaceuticals (2015), Pooled Investment Fund (2015), Biotechnology (2016–2020), Pooled Investment Fund (2021), Biotechnology (2021), Pharmaceuticals (2021), Biotechnology (2021), Pharmaceuticals (2021), Pooled Investment Fund (2021), Pharmaceuticals (2021), Biotechnology (2021), Pharmaceuticals (2022), Pooled Investment Fund (2022), Biotechnology (2024), Pharmaceuticals (2024–2025). Latest offering: Other Health Care (Oct 10, 2025).
| Name | Roles | Issuers here | First → last listed |
|---|---|---|---|
| Tighe Reardon | Executive Officer, Promoter, Director | 11 | Sep 11, 2015 → Oct 10, 2025 |
| Jay Lichter | Director | 6 | Jun 6, 2014 → Sep 11, 2025 |
| Douglas Downs | Promoter, Executive Officer, Director | 5 | Jul 19, 2010 → Aug 4, 2015 |
| Sanford Madigan | Executive Officer, Director | 4 | Aug 4, 2015 → Sep 11, 2025 |
| Kevin Kinsella | Promoter, Director | 4 | Jul 19, 2010 → Oct 14, 2020 |
| Stefan Heller | Director | 3 | Jul 13, 2020 → Jul 24, 2024 |
| Richard Levandov | Promoter | 3 | Jul 19, 2010 → Sep 13, 2016 |
| Braden M Bohrmann | Promoter | 3 | Jul 19, 2010 → Sep 13, 2016 |
| Stephen Tomlin | Promoter, Director | 3 | Jul 19, 2010 → Apr 26, 2013 |
| Sergio Duron | Executive Officer, Director | 2 | Mar 25, 2021 → Sep 11, 2025 |
| Jay Lichter, Ph.D. | Director | 2 | Jul 13, 2020 → Oct 8, 2021 |
| Court Turner | Executive Officer, Director | 2 | Jun 6, 2014 → Nov 15, 2016 |
| Jay B. Lichter | Promoter | 2 | Jul 19, 2010 → Aug 30, 2012 |
| Ahmet Tutuncu, M.D., Ph.D. | Executive Officer, Director | 1 | Oct 10, 2025 → Oct 10, 2025 |
| Heather Preston, M.D. | Director | 1 | Oct 10, 2025 → Oct 10, 2025 |
| John S. Patton, Ph.D | Director | 1 | Oct 10, 2025 → Oct 10, 2025 |
| Jay B. Lichter, Ph.D. | Director | 1 | Oct 10, 2025 → Oct 10, 2025 |
| Sanford Madigan, Ph.D. | Director | 1 | Oct 10, 2025 → Oct 10, 2025 |
| Shelley Chu | Director | 1 | Mar 25, 2021 → Sep 11, 2025 |
| James Topper | Director | 1 | Mar 25, 2021 → Sep 11, 2025 |
| Marcos Milla | Director | 1 | Mar 25, 2021 → Sep 11, 2025 |
| Stephen Squinto | Director | 1 | Aug 9, 2024 → Sep 11, 2025 |
| Miguel Garcia-Guzman | Executive Officer, Director | 1 | Jul 24, 2024 → Jul 24, 2024 |
| ABV SPV II GP, LLC entity | Director | 1 | Nov 23, 2022 → Nov 23, 2022 |
| Sanford J. Madigan, Ph.D. | Executive Officer, Director | 1 | Jul 13, 2020 → Oct 8, 2021 |
| Avalon BioVentures GP, LLC entity | Director | 1 | Jul 22, 2021 → Jul 22, 2021 |
| Peter Thompson, M.D. | Director | 1 | Mar 12, 2021 → Apr 30, 2021 |
| Sheila Gujrathi | Director | 1 | Apr 30, 2021 → Apr 30, 2021 |
| David Campbell, Ph.D. | Executive Officer, Director | 1 | Jul 14, 2020 → Apr 30, 2021 |
| Jake Simson, Ph.D. | Director | 1 | Mar 12, 2021 → Apr 30, 2021 |
| Vickie L. Capps | Director | 1 | Apr 30, 2021 → Apr 30, 2021 |
| ABV SPV I GP, LLC entity | Director | 1 | Feb 24, 2021 → Feb 24, 2021 |
| Andre Kobelt, Ph.D. | Director | 1 | Oct 14, 2020 → Oct 14, 2020 |
| Andrew Levin | Director | 1 | Jul 28, 2016 → Apr 27, 2018 |
| Peter A. Thompson | Director | 1 | Apr 27, 2018 → Apr 27, 2018 |
| Laura Shawver | Executive Officer, Director | 1 | Apr 27, 2018 → Apr 27, 2018 |
| Floyd Romesberg | Director | 1 | Jun 6, 2014 → Apr 27, 2018 |
| Jay M. Lichter | Promoter | 1 | Sep 11, 2015 → Sep 13, 2016 |
| Kevin Ober | Director | 1 | Mar 29, 2013 → Apr 26, 2013 |
| Thomas Bolt | Executive Officer, Director | 1 | Oct 24, 2012 → Apr 26, 2013 |
Not yet searched. Sources to be searched: SEC Investment Adviser Information Reports — Form ADV data for SEC-registered advisers and exempt reporting advisers (file dated 2026-10-02); SEC Investment Adviser Public Disclosure (IAPD) firm search — registered and exempt reporting advisers · Search queued. Results are added automatically; check back later.
Not yet searched.
Sources to be searched: the sponsor's website (none on record yet; a sponsor's website is known only from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim or Form ADV Item 1.I of its matched adviser — we never look it up elsewhere) for Meta Pixel ids and Facebook / Instagram page links; Meta Ad Library API: not yet searched (API access pending). We never read facebook.com or instagram.com; readers get a link to Meta's public Ad Library instead.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
No corrections have been requested for this page.
Free. Covers the grouping itself or any record shown here. Logged with status: received → under review → fixed / confirmed with source.
Add a sourced explanation next to any fact. Reviewed before publishing.